JP2004525957A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004525957A5 JP2004525957A5 JP2002580924A JP2002580924A JP2004525957A5 JP 2004525957 A5 JP2004525957 A5 JP 2004525957A5 JP 2002580924 A JP2002580924 A JP 2002580924A JP 2002580924 A JP2002580924 A JP 2002580924A JP 2004525957 A5 JP2004525957 A5 JP 2004525957A5
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- product
- pharmaceutical composition
- sodium caprate
- csf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FIWQZURFGYXCEO-UHFFFAOYSA-M sodium;decanoate Chemical compound [Na+].CCCCCCCCCC([O-])=O FIWQZURFGYXCEO-UHFFFAOYSA-M 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229960005480 sodium caprylate Drugs 0.000 claims 3
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 claims 3
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 208000004235 neutropenia Diseases 0.000 claims 2
- 208000019838 Blood disease Diseases 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000003812 Interleukin-15 Human genes 0.000 claims 1
- 108090000172 Interleukin-15 Proteins 0.000 claims 1
- 102000000588 Interleukin-2 Human genes 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 208000002720 Malnutrition Diseases 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 238000010322 bone marrow transplantation Methods 0.000 claims 1
- 230000001332 colony forming effect Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 208000014951 hematologic disease Diseases 0.000 claims 1
- 208000018706 hematopoietic system disease Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 235000018343 nutrient deficiency Nutrition 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28445801P | 2001-04-18 | 2001-04-18 | |
| US60/284,458 | 2001-04-18 | ||
| PCT/CA2002/000535 WO2002083120A2 (en) | 2001-04-18 | 2002-04-18 | Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009272679A Division JP5657879B2 (ja) | 2001-04-18 | 2009-11-30 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004525957A JP2004525957A (ja) | 2004-08-26 |
| JP2004525957A5 true JP2004525957A5 (https=) | 2009-08-20 |
| JP5026655B2 JP5026655B2 (ja) | 2012-09-12 |
Family
ID=23090294
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580924A Expired - Lifetime JP5026655B2 (ja) | 2001-04-18 | 2002-04-18 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| JP2009272679A Expired - Lifetime JP5657879B2 (ja) | 2001-04-18 | 2009-11-30 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| JP2014165557A Expired - Lifetime JP6420089B2 (ja) | 2001-04-18 | 2014-08-15 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009272679A Expired - Lifetime JP5657879B2 (ja) | 2001-04-18 | 2009-11-30 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| JP2014165557A Expired - Lifetime JP6420089B2 (ja) | 2001-04-18 | 2014-08-15 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US7745488B2 (https=) |
| EP (2) | EP1385498B1 (https=) |
| JP (3) | JP5026655B2 (https=) |
| KR (1) | KR20030096323A (https=) |
| CN (1) | CN1633286A (https=) |
| AP (1) | AP1740A (https=) |
| AU (2) | AU2002308456B2 (https=) |
| BG (1) | BG66418B1 (https=) |
| BR (1) | BR0208984A (https=) |
| CA (2) | CA2763637C (https=) |
| CY (1) | CY1107081T1 (https=) |
| CZ (1) | CZ305273B6 (https=) |
| DE (1) | DE60223670T2 (https=) |
| DK (2) | DK1900364T3 (https=) |
| EA (1) | EA007322B1 (https=) |
| EE (1) | EE200300510A (https=) |
| ES (2) | ES2439738T3 (https=) |
| HU (1) | HUP0303817A3 (https=) |
| IL (3) | IL158322A0 (https=) |
| MX (1) | MXPA03009436A (https=) |
| NO (1) | NO335105B1 (https=) |
| NZ (2) | NZ541140A (https=) |
| OA (1) | OA12506A (https=) |
| PL (2) | PL223348B1 (https=) |
| PT (2) | PT1385498E (https=) |
| SI (1) | SI1385498T1 (https=) |
| SK (1) | SK12772003A3 (https=) |
| TN (1) | TNSN03089A1 (https=) |
| WO (1) | WO2002083120A2 (https=) |
| ZA (1) | ZA200307778B (https=) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL158322A0 (en) | 2001-04-18 | 2004-05-12 | Prometic Biosciences Inc | Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| DK1592416T3 (da) * | 2003-02-07 | 2009-04-20 | Prometic Biosciences Inc | Fedtsyrer med middel kædelængde, glycerider og analoger som stimulatorer af erythropoiesis |
| JP5214880B2 (ja) | 2003-07-25 | 2013-06-19 | プロメティック、バイオサイエンシーズ、インコーポレーテッド | 中鎖脂肪酸の金属塩の製造 |
| US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
| US8241670B2 (en) * | 2004-04-15 | 2012-08-14 | Chiasma Inc. | Compositions capable of facilitating penetration across a biological barrier |
| KR20070063507A (ko) * | 2004-09-03 | 2007-06-19 | 프로메틱 바이오사이언시즈 인코포레이티드 | 면역조절작용과 화학방어활성을 가진 치환된 퓨리닐 유도체및 단독 또는 중쇄 길이 지방산이나 글리세리드와의 혼합사용 |
| US8071580B2 (en) | 2004-10-01 | 2011-12-06 | Prometic Biosciences Inc. | Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| MX2007003967A (es) * | 2004-10-01 | 2008-03-04 | Prometic Biosciences Inc | Alcoholes grasos con longitud de cadena media como estimuladores de hematopoyesis. |
| AU2006217544B8 (en) * | 2005-02-28 | 2012-04-05 | Alphabeta Ab | Compounds for reducing aggregation of amyloid beta-peptide |
| EP2669368B1 (en) * | 2006-05-17 | 2016-08-03 | Cognate Therapeutics, Inc. | Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates |
| EP2679224A1 (en) | 2007-08-01 | 2014-01-01 | University of Pittsburgh of the Commonwealth System of Higher Education | Nitro oleic acid modulation of type II diabetes |
| CN101878028A (zh) | 2007-11-02 | 2010-11-03 | 普罗米蒂克生物科学公司 | 作为肾保护剂的中链长度脂肪酸和甘油酯 |
| NZ586249A (en) | 2007-12-19 | 2012-05-25 | Prometic Biosciences Inc | A combination of medium-chain length fatty acids, salts or triglycerides, gemcitabine, and optionally erlotinib, for the treatment of pancreatic cancer |
| CN102083787A (zh) | 2008-05-01 | 2011-06-01 | 康普雷克萨公司 | 乙烯基取代的脂肪酸 |
| US20140024713A1 (en) | 2008-06-19 | 2014-01-23 | University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| WO2009155439A2 (en) * | 2008-06-19 | 2009-12-23 | University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| CN102176900B (zh) | 2008-09-17 | 2017-09-26 | 克艾思马有限公司 | 药物组合物和相关的给药方法 |
| EP2165713B1 (en) * | 2008-09-19 | 2012-11-14 | Nestec S.A. | Whey and thymus function |
| EP2459189A4 (en) | 2009-07-31 | 2013-01-16 | Univ Pittsburgh | FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS |
| WO2011041639A2 (en) | 2009-10-02 | 2011-04-07 | Miller Raymond A | Heteroatom containing substituted fatty acids |
| EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
| EP2744491B1 (en) | 2011-08-19 | 2020-07-29 | The University of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
| TWI572352B (zh) * | 2012-03-01 | 2017-03-01 | 波麥堤克藥學Ｓｍｔ有限公司 | 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法 |
| CN108498532B (zh) | 2012-05-09 | 2021-07-23 | 坎泰克斯制药股份有限公司 | 骨髓抑制的治疗 |
| KR101621856B1 (ko) | 2013-08-19 | 2016-05-17 | 한국생명공학연구원 | 모노아세틸디아실글리세롤 화합물을 유효성분으로 함유하는 류마티스 관절염의 예방 또는 치료용 조성물 |
| CA3037762C (en) | 2014-05-15 | 2022-03-22 | Enzychem Lifesciences Corporation | Methods for treating leukopenia and thrombocytopenia |
| HUE071943T2 (hu) | 2015-02-03 | 2025-10-28 | Amryt Endo Inc | Akromegália kezelése oktreotid orális alkalmazásával |
| US10052346B2 (en) | 2015-02-17 | 2018-08-21 | Cantex Pharmaceuticals, Inc. | Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids |
| HRP20240082T1 (hr) | 2015-07-07 | 2024-03-29 | H. Lundbeck A/S | Inhibitor pde9 s okosnicom imidazopirazinona za liječenje perifernih bolesti |
| IL258476B2 (en) | 2015-10-02 | 2023-04-01 | Complexa Inc | Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids |
| US9808438B2 (en) * | 2015-11-09 | 2017-11-07 | Enzychem Lifesciences Corporation | Method for treating mucositis |
| EP3928776B1 (en) | 2016-04-22 | 2025-11-12 | Spoke Sciences, Inc. | Fast-acting plant-based medicinal compounds and nutritional supplements |
| US11406616B2 (en) | 2016-06-08 | 2022-08-09 | Sunregen Healthcare Ag | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
| EA201892396A1 (ru) | 2016-12-02 | 2019-04-30 | Ресептор Лайф Сайенсиз, Инк. | Быстродействующие растительные лекарственные соединения и биологически активные добавки |
| CN107382710B (zh) * | 2017-08-19 | 2020-11-06 | 中国铁道科学研究院集团有限公司铁道建筑研究所 | 一种接枝抗氧剂分子的多元醇 |
| WO2019052629A1 (en) * | 2017-09-12 | 2019-03-21 | Sunregen Healthcare Ag | LIPIDS HAVING AN IMPERATIVE NUMBER OF CARBON ATOMS AND THEIR USE AS A PHARMACEUTICAL COMPOSITION OR FOOD SUPPLEMENT |
| MX2020003330A (es) * | 2017-10-05 | 2020-07-28 | Receptor Holdings Inc | Composiciones de hierbas con mejor biodisponibilidad. |
| CA3078549A1 (en) * | 2017-10-05 | 2019-04-11 | Receptor Holdings, Inc. | Rapid onset and extended action plant-based and synthetic cannabinoid formulations |
| KR102054401B1 (ko) * | 2018-03-26 | 2019-12-10 | 주식회사 엔지켐생명과학 | 1,2-디아실글리세롤 화합물, 그 제조방법 및 이를 유효성분으로 함유하는 면역조절제 |
| FI3801526T3 (fi) | 2018-05-25 | 2024-03-20 | Cardurion Pharmaceuticals Inc | 6-[(3s,4s)-4-metyyli-1-(pyrimidin-2-yylimetyyli)pyrrolidin-3-yyli]-3-tetrahydropyran-4-yyli-7h-imidatso[1,5-a]pyratsin-8-onin monohydraattimuotoja ja kiteisiä muotoja |
| EP3843737A4 (en) | 2018-08-31 | 2022-06-01 | Imara Inc. | PDE9 INHIBITORS FOR THE TREATMENT OF SICKLE CELL DISEASE |
| MA53188A1 (fr) | 2018-10-11 | 2021-12-31 | Basf As | Composés aromatiques et leurs utilisations pharmaceutiques |
| AU2019385420A1 (en) | 2018-11-19 | 2021-07-08 | Spoke Sciences, Inc. | N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions |
| JP7735864B2 (ja) * | 2019-10-31 | 2025-09-09 | 日本ゼオン株式会社 | 電気化学素子用機能層およびその製造方法、電気化学素子用機能層付きセパレータおよびその製造方法、並びに電気化学素子およびその製造方法 |
| US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
| US20240415798A1 (en) * | 2021-10-18 | 2024-12-19 | Enzychem Lifesciences Corporation | Compositions and methods for treating mucositis |
| CN119421865A (zh) * | 2022-04-21 | 2025-02-11 | 默沙东有限责任公司 | 制备附聚的结晶中链脂肪酸钠盐的方法 |
| WO2026013252A1 (en) * | 2024-07-12 | 2026-01-15 | Paoli Alessio | A mixture of mono-, di- and triglycerides of nonanoic acid for use in the treatment of muscle atrophy, sarcopenia and muscle-injury |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2002A (en) * | 1841-03-12 | Tor and planter for plowing | ||
| US2004A (en) * | 1841-03-12 | Improvement in the manner of constructing and propelling steam-vessels | ||
| US2008A (en) * | 1841-03-18 | Gas-lamp eok conducting gas pkom ah elevated buhner to one below it | ||
| US2003A (en) * | 1841-03-12 | Improvement in horizontal windivhlls | ||
| US2006A (en) * | 1841-03-16 | Clamp for crimping leather | ||
| US4528197A (en) * | 1983-01-26 | 1985-07-09 | Kabivitrum Ab | Controlled triglyceride nutrition for hypercatabolic mammals |
| US4703062A (en) * | 1984-01-16 | 1987-10-27 | Baxter Travenol Laboratories, Inc. | Parenteral nutrition with medium and long chain triglycerides |
| US4871768A (en) | 1984-07-12 | 1989-10-03 | New England Deaconess Hospital Corporation | Dietary supplement utilizing ω-3/medium chain trigylceride mixtures |
| US4816440A (en) * | 1985-09-26 | 1989-03-28 | Cetus Corporation | Stable formulation of biologically active proteins for parenteral injection |
| US7307166B1 (en) * | 1987-10-28 | 2007-12-11 | Wellstat Therapeutics Corporation | Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis |
| US5011852A (en) * | 1988-07-25 | 1991-04-30 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
| JPH02134326A (ja) * | 1988-11-14 | 1990-05-23 | Snow Brand Milk Prod Co Ltd | 高度侵襲用経腸栄養剤 |
| JP3249147B2 (ja) * | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
| FI924778A0 (fi) * | 1991-02-22 | 1992-10-21 | Amgen Inc | Anvaendning av gm-csf och g-csf foer foersnabbande av saorlaekning |
| JP3132085B2 (ja) * | 1991-09-06 | 2001-02-05 | ウェルファイド株式会社 | 脂肪乳剤 |
| JPH05163160A (ja) * | 1991-12-13 | 1993-06-29 | Snow Brand Milk Prod Co Ltd | 免疫低下に伴う感染症の予防及び治療用栄養剤 |
| US5214035A (en) * | 1992-04-16 | 1993-05-25 | Hoechst-Roussel Agri-Vet Company | Thixotropic formulations |
| US5308832A (en) * | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
| US5318781A (en) * | 1993-04-06 | 1994-06-07 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| US20010003739A1 (en) | 1993-06-24 | 2001-06-14 | Astrazeneca Ab | Systemic administration of a therapeutic preparation |
| US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
| AU7082694A (en) * | 1994-05-10 | 1995-11-29 | Kitasato Institute, The | Hematopoietic stem cell proliferation accelerator |
| US5470861A (en) * | 1994-08-04 | 1995-11-28 | Hoffmann-La Roche Inc. | Method of promoting hair growth |
| US5549905A (en) * | 1994-10-18 | 1996-08-27 | Clintec Nutrition Co. | Enternal composition for pediatric patients |
| JPH08208510A (ja) | 1994-11-03 | 1996-08-13 | F Hoffmann La Roche Ag | インターフェロン組成物 |
| GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
| US5733884A (en) * | 1995-11-07 | 1998-03-31 | Nestec Ltd. | Enteral formulation designed for optimized wound healing |
| CN1259908C (zh) * | 1995-11-28 | 2006-06-21 | B·布朗·梅尔松根有限公司 | 最优化水解的脂质乳剂及其用途 |
| AUPN933396A0 (en) * | 1996-04-17 | 1996-05-09 | Pfizer Pty Limited | Non-aqueuos oral-drench compositions containing avermectin compounds |
| US5851534A (en) * | 1996-05-03 | 1998-12-22 | Dynagen, Inc. | Methods for prevention and/or treatment of neutropenia |
| JPH10265380A (ja) * | 1997-03-17 | 1998-10-06 | Bristol Myers Squibb Co | 抗ガン剤 |
| US6017531A (en) * | 1997-06-02 | 2000-01-25 | W. R. Grace & Co. | Hydrophilic composition containing protease produced by Vibrio |
| AU9221698A (en) | 1997-09-04 | 1999-03-22 | Biozone Laboratories, Inc. | Oral liposomal delivery system |
| ES2238775T3 (es) * | 1997-11-19 | 2005-09-01 | Hercules Incorporated | Suspensiones polimericas fluidificadas de polisacaridos cationicos en emolientes y su uso en la preparacion de composiciones para el cuidado personal. |
| EP1061932B1 (en) | 1997-11-20 | 2006-01-25 | Gil Ja Jhon | Pharmaceutical composition containing extracts of cervus nippon antlers having growth-stimulating activities of hematopoietic stem cells and megakaryocytes |
| DE69910183T2 (de) | 1998-03-11 | 2004-06-03 | Grelan Pharmaceutical Co., Ltd., Hamura | Darmlösliche sprudelnde zusammensetzungen |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| KR20020059415A (ko) * | 1999-09-27 | 2002-07-12 | 스티븐 씨. 큐웨이 | 토콜-가용성 치료요법제 |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| AU2001264079A1 (en) * | 2000-06-14 | 2001-12-24 | William Leslie Porter | Lipids for modulating immune response |
| ES2234877T5 (es) * | 2000-06-20 | 2010-10-18 | Nutrition Sciences | Acidos grasos de cadena media utilizables como agentes antimicrobianos. |
| US6967028B2 (en) * | 2000-07-31 | 2005-11-22 | Mainelab | Prolonged release microspheres for injectable administration |
| IL142535A0 (en) | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
| IL158322A0 (en) | 2001-04-18 | 2004-05-12 | Prometic Biosciences Inc | Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| US20040052836A1 (en) | 2002-09-13 | 2004-03-18 | Li Luk Chiu | Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life |
| DK1592416T3 (da) | 2003-02-07 | 2009-04-20 | Prometic Biosciences Inc | Fedtsyrer med middel kædelængde, glycerider og analoger som stimulatorer af erythropoiesis |
| US6725510B1 (en) * | 2003-04-25 | 2004-04-27 | Almetta Clyburn | Inclining coffin |
| JP5214880B2 (ja) | 2003-07-25 | 2013-06-19 | プロメティック、バイオサイエンシーズ、インコーポレーテッド | 中鎖脂肪酸の金属塩の製造 |
| KR20070063507A (ko) * | 2004-09-03 | 2007-06-19 | 프로메틱 바이오사이언시즈 인코포레이티드 | 면역조절작용과 화학방어활성을 가진 치환된 퓨리닐 유도체및 단독 또는 중쇄 길이 지방산이나 글리세리드와의 혼합사용 |
| US8071580B2 (en) | 2004-10-01 | 2011-12-06 | Prometic Biosciences Inc. | Medium-chain length fatty alcohols as stimulators of hematopoiesis |
-
2002
- 2002-04-18 IL IL15832202A patent/IL158322A0/xx active IP Right Grant
- 2002-04-18 DK DK07116425.5T patent/DK1900364T3/da active
- 2002-04-18 BR BR0208984-0A patent/BR0208984A/pt not_active Application Discontinuation
- 2002-04-18 EP EP02761857A patent/EP1385498B1/en not_active Expired - Lifetime
- 2002-04-18 CA CA2763637A patent/CA2763637C/en not_active Expired - Lifetime
- 2002-04-18 CA CA2444463A patent/CA2444463C/en not_active Expired - Lifetime
- 2002-04-18 PT PT02761857T patent/PT1385498E/pt unknown
- 2002-04-18 EE EEP200300510A patent/EE200300510A/xx unknown
- 2002-04-18 EP EP07116425.5A patent/EP1900364B1/en not_active Expired - Lifetime
- 2002-04-18 NZ NZ541140A patent/NZ541140A/en not_active IP Right Cessation
- 2002-04-18 CN CNA028094263A patent/CN1633286A/zh active Pending
- 2002-04-18 NZ NZ528690A patent/NZ528690A/en not_active IP Right Cessation
- 2002-04-18 PL PL366435A patent/PL223348B1/pl unknown
- 2002-04-18 CZ CZ2003-2685A patent/CZ305273B6/cs not_active IP Right Cessation
- 2002-04-18 AU AU2002308456A patent/AU2002308456B2/en not_active Expired
- 2002-04-18 OA OA1200300273A patent/OA12506A/en unknown
- 2002-04-18 SI SI200230655T patent/SI1385498T1/sl unknown
- 2002-04-18 AP APAP/P/2003/002888A patent/AP1740A/en active
- 2002-04-18 EA EA200301131A patent/EA007322B1/ru not_active IP Right Cessation
- 2002-04-18 JP JP2002580924A patent/JP5026655B2/ja not_active Expired - Lifetime
- 2002-04-18 KR KR10-2003-7013555A patent/KR20030096323A/ko not_active Ceased
- 2002-04-18 DK DK02761857T patent/DK1385498T3/da active
- 2002-04-18 PT PT71164255T patent/PT1900364E/pt unknown
- 2002-04-18 PL PL402948A patent/PL222876B1/pl unknown
- 2002-04-18 SK SK1277-2003A patent/SK12772003A3/sk unknown
- 2002-04-18 ES ES07116425.5T patent/ES2439738T3/es not_active Expired - Lifetime
- 2002-04-18 ES ES02761857T patent/ES2295397T3/es not_active Expired - Lifetime
- 2002-04-18 MX MXPA03009436A patent/MXPA03009436A/es active IP Right Grant
- 2002-04-18 HU HU0303817A patent/HUP0303817A3/hu unknown
- 2002-04-18 DE DE60223670T patent/DE60223670T2/de not_active Expired - Lifetime
- 2002-04-18 US US10/475,266 patent/US7745488B2/en not_active Expired - Lifetime
- 2002-04-18 WO PCT/CA2002/000535 patent/WO2002083120A2/en not_active Ceased
-
2003
- 2003-07-08 TN TNPCT/CA2002/000535A patent/TNSN03089A1/en unknown
- 2003-10-06 ZA ZA200307778A patent/ZA200307778B/en unknown
- 2003-10-09 IL IL158322A patent/IL158322A/en unknown
- 2003-10-17 NO NO20034644A patent/NO335105B1/no not_active IP Right Cessation
- 2003-10-17 BG BG108280A patent/BG66418B1/bg unknown
-
2006
- 2006-03-21 AU AU2006201163A patent/AU2006201163B2/en not_active Expired
-
2007
- 2007-12-12 CY CY20071101574T patent/CY1107081T1/el unknown
-
2008
- 2008-11-10 IL IL195200A patent/IL195200A/en active IP Right Grant
-
2009
- 2009-11-30 JP JP2009272679A patent/JP5657879B2/ja not_active Expired - Lifetime
-
2010
- 2010-06-11 US US12/814,028 patent/US8487001B2/en not_active Expired - Fee Related
-
2014
- 2014-08-15 JP JP2014165557A patent/JP6420089B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004525957A5 (https=) | ||
| Sonis | Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity | |
| Deng et al. | Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening | |
| EP2105136A3 (en) | Pharmaceutical compositions for treating cancer | |
| CA2444463A1 (en) | Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors | |
| WO2005048950A3 (en) | Tumor and infectious disease therapeutic compositions | |
| US20180099141A1 (en) | System and method for reducing inflammation of tissue | |
| Antunes et al. | Oral and maxillofacial myiasis: a case series and literature review | |
| JP2006502132A5 (https=) | ||
| Alkan et al. | Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era | |
| EP2319531A3 (en) | Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds | |
| CA2520515A1 (en) | S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment | |
| ATE74272T1 (de) | Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie. | |
| Ullmann et al. | of Inf ectious Diseases | |
| DE69832902T2 (de) | Oromukosal-zytokin-zusammensetzungen und ihre verwendung | |
| JP2021512164A5 (https=) | ||
| WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
| RU2332227C1 (ru) | Способ комплексной терапии больных с плоскоклеточным раком слизистой полости рта | |
| Tilg et al. | Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression? | |
| DE60130775D1 (de) | Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen | |
| EP2161032A3 (en) | Methods of healing wounds by administering human IL-18 | |
| JP2003528139A5 (https=) | ||
| CA2384418A1 (en) | Use of cytokines, cells, and mitogens to inhibit graft versus host disease | |
| SE0400942D0 (sv) | Composition and method | |
| Davletshina et al. | Prospective methods of vitiligo treatment (literature review) |